Submitted by Anonymous (not verified) on 25 August 2023 - 14:32
Human medicines European public assessment report (EPAR): Xultophy, insulin degludec,liraglutide, Diabetes Mellitus, Type 2, Date of authorisation: 18/09/2014, Revision: 16, Status: Authorised
Source: